Treatment Registry

Company

AVARA Rx

AVARA Rx publishes compounded semaglutide and compounded tirzepatide, from $179 to $229 a month.

Published by Treatment Registry · Latest research

  • 2 programs
  • 2 identified molecules
  • 2 readings

Read from avararx.com; latest program check September 2026. Individual programs and sources may have earlier verification dates.

Go to AVARA Rx

Visit AVARA Rx

We earn nothing from this link. It opens AVARA Rx's website without a paid referral.

What it costs

first month, including required fees on record · ◯ $179 advertised · Starting price (promo code AVARA50 applied)

first month, including required fees on record · ◯ $229 advertised · Starting price (promo code AVARA50 applied)

Terms

Membership

Required, $149 per month. Starting at $149 *$149 for the provider consultation and follow ups only. Price of the medication(s) are charged upon consult approval. Your Medication will be shipped through NovoCare.

Across recorded programs · Evidence: September 2026

States

Not disclosed

Across recorded programs · Evidence: September 2026

Not yet checked: pharmacy and consultation fee.

Programs

EntryProgramPer month
at its shortest term
Link
EntryTR-0572ProgramCompounded semaglutidePer month at shortest term$179
Starting price (promo code AVARA50 applied)
Record
EntryTR-0573ProgramCompounded tirzepatidePer month at shortest term$229
Starting price (promo code AVARA50 applied)
Record

Notes

Pricing details, service terms and questions to confirm before enrolling.

September 2026

  1. 1. AVARA Rx sells two separate product lines under the same drug names: compounded semaglutide/tirzepatide with a genuine bundled monthly price (recorded in entries above), and separate 'GLP Branded Medications' pages (Wegovy Consultation, Wegovy Pill Consultation, Zepbound Consultation, Foundayo Consultation) all listing 'Starting at $149' -- but every one of those pages carries the explicit disclaimer that the $149 is the consultation fee only and 'Price of the medication(s) are charged upon consult approval,' so per the brief's rule this is a membership/consult fee, not a program price, and no branded-medication price could be found. 'Foundayo®' is listed as a branded GLP-1 product but its own page never states which active ingredient it contains (semaglutide, tirzepatide, or another named brand), so it could not be assigned to any of the six allowed drug values and is omitted from entries.

Understand the terms

Before you act

Cite this

Treatment Registry. (2026). AVARA Rx: recorded programs and prices. Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/avara-rx